Clinical Trial Update: Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety and efficacy of subcutaneously injected risankizumab in adults with genital or scalp psoriasis; results have been completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Psoriasis
• Scalp Psoriasis

Drugs mentioned

• Risankizumab (risankizumab)

Snippet

Sponsor: AbbVie | Conditions: Genital Psoriasis, Scalp Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2026-02-24